Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of dermatological drugs specializing on the fields of photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Biofrontera Inc.

#NowHiring: The #Biofrontera team is searching for a new Jr. Territory Manager in Chicago, IL! 

If you're ready to make a difference in #dermatology, visit ⤵️

#SalesPosition #ComeGrowWithUs

📢 We're hiring a Territory Manager in Chicago, IL! 

Ready to help the #Biofrontera team spread the word about our innovative dermatological treatments? Apply today ⤵️ 

#ComeGrowWithUs

Today we shared #Bioftonera's #Q3 financial results for 2023. To learn more, visit the link below: ⤵️

#BiofronteraNews #Dermatology

Meet #Biofrontera Quality Assurance Director, Darrell Lowman! Darrell has been instrumental in our success as a company and is a natural-born leader. We are lucky to have him!

To learn more about our team, visit: https://loom.ly/xeWeBoE

#GetToKnowUs #PDT #EmployeeSpotlight #Dermatology

Are you a #Dermatology NP or PA and looking to transition to industry? Are you located in the Northeast? Do you want to join a dynamic team and fuel your career growth? If so, please check out #Biofrontera's open position for a Medical Science Liaison. ⤵️

#ComeGrowWithUs #NowHiring

#Biofrontera was happy to support and take part in the YoungMD Connect Networking Event this weekend in Chicago, connecting with some of the rising stars of #dermatology!

Thank you to Sally Cioci Fischer and the Practical Dermatology team for organizing such a great event!

Mouna Mikati, Ph.D. Kristina Malkhasova, Pharm. D. 

#BiofronteraontheMove

Join the #Biofrontera team as a Senior Financial Analyst at our headquarters in Woburn, MA! 

Discover how you can help to make a difference in #dermatology. Apply now ⤵️

We had a great time at the Ohio Dermatological Annual Meeting this past weekend! It's always a pleasure running into Dr. Scott Drew and Delaney Drew.

Thank you to our own Amy Ward Cline for holding down the booth and sharing the latest about 

#Biofrontera! #BiofronteraOnTheMove #Dermatology

We have news! To learn more about the latest #Biofrontera updates, visit: https://loom.ly/ZfcmM4o

#BiofronteraNews #Dermatology

Happy Halloween from all of us at #Biofrontera! Our latest training class joined some of our HQ team for a spooktacular time at our annual Halloween celebration. 

We celebrated with a costume contest as well a painting contest and DIY cookie decorating!

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

COM:BIOFRONTERA-US

Biofrontera Inc.

Last Close

0.76

22/11 21:00

Market Cap

4.99M

Beta: -

Volume Today

7.71M

Avg: -

Filings Not Available